12 Hrs
Source:
The Guardian
The Guardian
Ready to play
Ready to play
The UK health secretary announced the expansion of the Transform trial to include more black men and those with BRCA2 gene mutations to improve prostate cancer testing, amid recommendations against population-wide screening using PSA tests. The decision follows guidance from the UK national screening committee, which cited concerns about the risks and benefits of widespread screening, and will focus on high-risk groups, with a rollout expected in 2027. Critics argue that this approach may perpetuate inequalities and limit early detection efforts.
Notice: This Is an AI-Generated Summary
Comments (0)